11 insiders reported 176 Form 4 transactions for Enliven Therapeutics, Inc. (ELVN) over the past 18 months (most recent 2026-09-21). Recent activity: Collins Helen Louise (CHIEF MEDICAL OFFICER) Buy 5,000 shares, Hohl Benjamin (CHIEF FINANCIAL OFFICER) Buy 3,982 shares, Collins Helen Louise (CHIEF MEDICAL OFFICER) Sell 2,916 shares, Hohl Benjamin (CHIEF FINANCIAL OFFICER) Sell 3,535 shares, Collins Helen Louise (CHIEF MEDICAL OFFICER) Sell 1,844 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-09-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Buy | 3,982 | $59,133 |
| 2026-09-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 2,916 | $145,891 |
| 2026-09-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,535 | $176,851 |
| 2026-09-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 1,844 | $93,507 |
| 2026-09-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 2,194 | $111,270 |
| 2026-09-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 240 | $12,356 |
| 2026-09-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 289 | $14,881 |
| 2026-08-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 1,100 | $65,281 |
| 2026-08-19 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,630 | $270,168 |
| 2026-08-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 3,900 | $227,650 |
| 2026-08-19 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,388 | $82,383 |
| 2026-08-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 87,373 | $216,685 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 27,567 | $696,894 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 23,364 | $346,955 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 20,491 | $460,433 |
| 2026-08-06 | Derynck Mika K | Director | Sell | 158,795 | $9.6M |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Buy | 1,072 | $2,659 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 231 | $11,563 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 324 | $16,191 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 459 | $23,660 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 369 | $18,997 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 2,063 | $108,085 |
Source: SEC Form 4 filings · as of 2026-09-21